SARS-CoV2 Infection in a Multiple Sclerosis Patient Treated with Natalizumab – A Case Presentation

Publicado en línea: 29 sept 2020

Páginas: 110 - 112

Recibido: 20 ago 2020

Aceptado: 01 sept 2020

DOI: https://doi.org/10.2478/amma-2020-0022

Palabras clave

multiple sclerosis, Natalizumab, SARS-CoV2 infection, COVID-19 outbreak

© 2020 Georgiana Șerban et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.